Global vaccine program COVAX low on funds, seeks $5.2bn

GENEVA: The global initiative to share coronavirus vaccines equally between rich and poor countries asked Wednesday for $5.2 billion in funds to be able to keep buying doses in the coming months. The UN-backed program known as COVAX has delivered just over 1 billion doses since shipments started nearly a year ago. The initial goal was to deliver 2 billion doses by the end of 2021, but COVAX's lack of cash when vaccine deals were being made gave it a late start, and most of the world's vaccine doses have gone to wealthy nations who locked in contracts. As things stand now, less than 10% of the people in low-income countries have received at least one dose, while more than 60% of the world's overall population has been vaccinated — some with three or four doses. Seth Berkley, the CEO of GAVI, the global health organisation that co-founded the COVAX initiative, said it was key to supplying poor countries with vaccine shots now and in the future but "we right now are basically out of money." By RSS/AP READ ALSO:

• Nepal receives 1,965,600 doses of Moderna vaccine under COVAX facility
• Prior infection, vaccines provide best protection from Covid 19
• WHO, top US scientists say Omicron no worse than other virus variants